Abstract-Hepatic glutathione content decreased in a dose-dependent manner after the administration of lead acetate (5-100 mg/kg, i.p.). Hepatic cysteine content, a substantial rate limiting factor in glutathione synthesis, also decreased transiently but significantly, whereas total cysteine (cysteine plus cystine) content remained un changed. The pretreatment of mice with L-methionine (250 mg/kg, i.p.) partially prevented the decrease in glutathione content in lead-treated mice at least partly through the elevation of hepatic cysteine content; in contrast, L-cysteine adminis tration (250 mg/kg, i.p.) depleted hepatic glutathione contrary to a quick increase in hepatic cysteine content. The activity of r-glutamylcysteine synthetase (GCS), a rate limiting enzyme in glutathione synthesis, was not altered by either the adminis tration of lead or sulfur amino acids. On the other hand, lead facilitated the disap pearance of glutathione from the livers of mice treated with buthionine sulfoximine, a specific inhibitor of GCS. These lines of evidence suggest that for the decrease in glutathione content elicited by lead-loading, the increased efflux of glutathione into extra-hepatic spaces is a more crucial event than the fluctuation of intrahepatic r ,ctninn rnnrAntrntinn
In mammalian livers, glutathione has an important role in detoxification of heavy metals as well as electrophilic organocom pounds (1, 2). Several studies have shown that the effect of inorganic lead on hepatic glutathione content varied from case to case; a single injection of lead decreased gluta thione content (3), whereas long-term lead exposure increased hepatic glutathione con tent (4, 5). Furthermore, increased gluta thione content via lead administration has resulted in reducing the toxicity of other electrophilic xenobiotics such as bromoben zene (6) or aflatoxin B1 (7). Thus the alter ation in the status of glutathione induced by lead may concern not only the occurrence of lead intoxication but the metabolic fates of other xenobiotics as well as drugs. The metabolism of glutathione under insult of lead, however, is known to a limited extent.
Although one could explain the increase in glutathione content in chronically lead treated mice as a compensatory response, there has been little information on events causing the difference in glutathione content between the acute and chronic administration of lead. The factors related to the exposure situation of lead or species of animals may contribute to the difference. The present experiments were undertaken to elucidate first the alterations in hepatic glutathione metabolism in mice after acute lead administration by measuring glutathione content, cysteine content, and the activity of a key enzyme in glutathione synthesis, i.e., r glutamylcysteine synthetase (GCS). In addi tion, the half-life of hepatic glutathione was calculated to assess the effect of lead on the efflux of glutathione out of livers by use of a glutathione synthesis inhibitor. Experimental procedures: L-Methionine, L cysteine, BSO (6 mmol/kg) and lead acetate were injected 1ntraperitonea Ily. Animals were killed between 10:00 and 13:00 hr to minimize the effects of diurnal rhythms, and parallel assays were run on control groups for each experiment. After animals were killed by cervical dislocation, livers were perfused with cold 0.9% NaCI solution from the portal vein. Then the livers were promptly removed and weighed.
Materials and Methods

Drugs
Total glutathione (reduced plus oxidized glutathiones) was assayed by the enzymatic cycling method modified by Adams et al. (8) in the presence of 0.25 mM bis(3-carboxy 4-nitrophenyl)disulfide (DTNB). 0.22 mM NADPH, and glutathione reductase (1 Unit). In short, 50 mg of liver was homogenized in 5 ml of 10 mM DTNB solution and then diluted 10-fold with 100 mM potassium phosphate buffer (pH 7.5) containing 5 mM ethylene diamine tetraacetic acid. After centrifugation at 2,000 x g for 3 min, the supernatant was used for measurement of glutathione. The reaction was followed by monitoring the change in absorbance at 412 nm with a Hitachi double beam spectrophotometer. The contents of glutathione were expressed as reduced glutathione equivalents.
Cysteine in the liver, extracted with 5% perchloric acid, was assayed spectropho tometrically according to the method of Gaitonde (9) using acid ninhydrin reagent. Total cysteine (cysteine plus cystine) was determined after cystine was reduced to cysteine by the addition of 5 ,umol dithio threitol at a neutral pH.
GCS activity in the liver was assayed spectrophotometrically according to the method of Sekura and Meister (10) .
Protein was measured according to the method of Lowry et al. (11) using bovine serum albumin as the standard.
Statistical significance of the results was determined by Student's t-test, and P values less than 0.05 were considered significant .
Results Dose-dependent effect of lead on hepatic glutathione content: As shown in Fig. 1 , the contents of glutathione (the sum of reduced and oxidized forms of glutathiones) were de creased in a dose-dependent manner 3 hr after a single injection (i.p.) of lead acetate. Four days after the injection, hepatic glu tathione contents in lead-treated mice except at a dose of 100 mg/kg were almost restored to the control level (K. Nakagawa, unpub lished observation; cf. Table 2 ). Intrahepatic cysteine content: Table  1 shows cysteine contents in the livers of mice treated with 100 mg/kg of lead acetate. Cysteine contents in lead-treated mice were significantly lowered 3 hr after the injection, whereas total cysteine (cysteine plus cystine) contents were not greatly affected by lead ad ministration. No significant effect of lead on cysteine contents was observed 4 days after the injection. in L-methionine-treated mice increased slowly and reached maximum 60 min after the injection.
Hepatic glutathione contents in mice treated with lead acetate and sulfur amino acids: The effects of pretreatment of L methionine and L-cysteine on the decrease in hepatic glutathione contents induced by lead were examined, because the administration of these sulfur amino acids was able to raise the cysteine content. Either sulfur amino acid (250 mg/kg) was injected intraperitoneally 60 min before lead administration (100 mg/ kg, i.p.), and hepatic glutathione contents were determined 3 hr and 4 days after lead administration. As shown in Table 2 , glu tathione content in mice treated with both methionine and lead was not statistically different from that in control or lead-treated mice. In contrast, L-cysteine, given alone or together with lead, diminished glutathione content greatly.
The effects of methionine pretreatment on total cysteine content and GCS activity in the livers of lead-treated mice: Figure 3 shows total cysteine contents in the livers of mice pretreated with L-methionine (250 mg/kg, i.p.) 1 hr before lead administration (100 mg/ kg). At early stages of the time course ex amined, cysteine contents in mice treated with both lead and L-methionine were higher than those in mice treated with lead alone.
The activity of GCS, a rate limiting enzyme in glutathione synthesis, in the livers of these animals was examined 3 hr after the lead ad ministration. Lead administration had no effect on GCS activity as indicated by the following data: the means±S.E.M. of GCS activities (nmol/mg protein/min) in mice treated with saline (control), lead (100 mg/ kg) alone, methionine (250 mg/kg) alone, and both methionine (250 mg/kg) and lead (100 mg/kg) were 63±14, 79±8, 55±9 and 59±9, respectively (5 animals for each group). Table 1 . Total cysteine (cysteine plus cystine) and cysteine contents in the liver after administration of lead acetate (100 mg/kg, i.p.)
Total cysteine (cysteine plus cystine) was determined after reduction with dithiothreitol as described in the text and expressed as cysteine equivalents . Animals were killed 3 hr or 4 days after injection of lead acetate (100 mg/kg).
Each figure represents the mean±S .E.M. of the number of animals indicated in parentheses. aP<0.05, significantly different from the control.
Additionally, GCS activity 4 days after lead administration (100 mg/kg) remained un changed (66±7 nmol/mg protein/min± S.E.M. from six control mice vs. 76±15 nmol/ mg protein/min±S.E.M.
from six lead-treated mice).
Effect of lead on disappearance of glu tathione in the liver of BSO-treated mice: Lead acetate (100 mg/kg) was injected in traperitoneally 10 min after administration of BSO (6 mmol/kg, i.p.), a potent inhibitor of GCS. Then glutathione contents in the livers were determined 30, 45, 60, 90 and 120 min after BSO administration and plotted on a semilogarithmic graph (Fig. 4) ; The data indicated that lead facilitated the disap pearance of glutathione from the livers. On the assumption that the elimination of glu Table 2 . Total glutathione (reduced and oxidized glutathiones) content in the liver 3 hr and 4 days after lead administration Sulfur amino acids were injected intraperitoneally 1 hr before lead acetate administration (100 mg/kg, i.p.). Total glutathione content was expressed as reduced glutathione equivalents. Each figure re presents the mean±S.E.M. of the number of animals indicated in parentheses.
N.D., not determined. aP<0 .01 and by<0.001, significantly different from the saline-pretreated control. tathione followed first-order kinetics, an ap parent elimination half-life of hepatic glu tathione was obtained graphically; the half life of glutathione (the mean±S.E.M. of three separate experiments) in lead-treated mice was 49±6 min, while that in the control was 96±15 min. The difference between the two groups was statistically significant (P<0.05). The half-life of hepatic glutathione in mice 4 days after lead administration (100 mg/kg) was also determined. The value, 105±28 min (the mean±S.E.M., n=3), was not statistically different from either the control value or the shortened value by lead stated above.
Discussion
Several investigators have documented that treatment of rats with lead produced in creases in hepatic glutathione content (4, 6, 7). One possible explanation for these rises in glutathione content was a compensatory mechanism supplying sufficent glutathione to overcome lead toxicity. Contrary to these re ports, the present results show that the acute administration of lead to mice decreased hepatic glutathione content in accordance with the results in mice reported by Dalvi and Robbins (3). However, it is not clear at present whether species differences exist or not.
Diethyl maleate, the most widely-used depleting agent, has been reported to in crease the hepatic glutathione content to more than normal levels after an initial de pletion period (12) . As for the existence of a rebound phase of glutathione content in lead treated mice, further studies are needed. Such studies may also contribute to clarifying the discrepancy between the present results and the previous observations in glutathione content.
Since the metabolism of glutathione under lead-loading has not been understood in detail so far, effects of lead on the biosynthesis of glutathione in the liver were first examined. The activity of GCS, a key enzyme for the synthesis of glutathione, was insensitive to lead. Besides, the concentration of cysteine, a substantial rate-limiting factor in glutathione biosynthesis because of lower intracellular concentration than the apparent Km value of GCS for the substrate cysteine (13, 14) , was found to be decreased only transiently in lead-treated mice, while total cysteine con tents remained unchanged. Since the major metabolic fate of cystine is conversion to cysteine (15) , it is unlikely that the temporary decrease in intrahepatic cysteine contents was of the first importance for the lead induced depletion of glutathione lasting at least four days.
The increase in cysteine content was pro minent in mice treated with both L-meth ionine and lead at early stages, indicating the rise in influx of sulfur into the glutathione synthesis pathway probably through a trans sulfuration pathway in lead-treated mice. Nevertheless, the result that glutathione con tent in mice treated with both methionine and lead did not significantly differ from that in mice treated with lead alone implies that pre treatment of methionine was not completely successful in counteracting the decrease in glutathione in lead-treated mice. Some factors other than cysteine content are likely to concern the decrease in glutathione content in lead-treated mice.
On the other hand, a bolus administration of L-cysteine, which promptly produced high intrahepatic concentration of cysteine, di minished hepatic glutathione content and failed to counteract the depletion of glu tathione induced by lead. The decrease in glutathione content caused by L-cysteine pretreatment may be ascribed in part to the autoxidation of cysteine, which results in consumption of glutathione by reaction with thiyl radicals and hydroxyl radicals produced in the cells (16) . The production of free radical species could involve the propagation of lipid peroxidation, which possibly results in the leak of glutathione or the depression of glutathione synthesis because of damage to the cell membrane or to an apparatus such as the amino acid transport systems. These results in mice pretreated with L-methionine or L-cysteine also suggest that the fluctuation of intrahepatic cysteine concentration is in capable of being a primary cause responsible for the depletion of glutathione in lead treated mice.
The present finding that lead treatment accelerated the disappearance of glutathione from the livers of BSO-treated mice seems to be a clue to clarify mechanisms underlying the alteration in glutathione metabolism in lead treated mice. Since lead has a high affinity for glutathione (17) , chelation of lead by glu tathione, similar to the conjugation of electro philic xenobiotics with glutathione, may be followed by the excretion to extrahepatic spaces. In fact, several workers have recently shown the excretion of lead into bile occurred in a glutathione dependent biological process in some species of animals (18, 19) .
Furthermore, in relation to hepatic glu tathione metabolism, the importance of glu tathione translocation across cell mem branes has been emphasized on the basis of the degradative pathway peculiar to this tripeptide, which is characterized by the fol lowing (20, 21) 
